InsidersTradesSigma
Explore the full record of transactions filed by Doebele Robert, Dirigeant. Director active across 1 companies, notably Rain Therapeutics Inc.. Cumulatively, 2 filings have been recorded. The latest transaction was disclosed on 13 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Robert Doebele is an Executive at Rain Therapeutics Inc. He is involved in the company's operations, which specializes in developing oncology treatments. Robert brings significant experience in the biotechnology field, contributing to the innovation and growth of the company.